|
ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping
|
5R44CA210820-02
|
$989,401
|
|
FRANGIONI, JOHN
|
CURADEL, LLC
|
|
Yale Cancer Center NCTN
|
5U10CA180826-05
|
$700,035
|
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
WNT4 IN ENDOCRINE RESPONSE AND RESISTANCE IN INVASIVE LOBULAR CARCINOMA
|
5R00CA193734-04
|
$218,349
|
|
SIKORA, MATTHEW
|
UNIVERSITY OF COLORADO DENVER
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-05
|
$542,950
|
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Whole-of-Community Systems Intervention for Youth Population Physical Activity
|
1R01CA215420-01A1
|
$512,891
|
|
DZEWALTOWSKI, DAVID
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Weight Management Counseling in Medical Schools: A Randomized Controlled Trial
|
5R01CA194787-03
|
$573,115
|
|
OCKENE, JUDITH
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-05
|
$1,394,352
|
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Vitamin D and Progestins for the Chemoprevention of Fallopian Tube/Ovarian Cancer
|
1R01CA214606-01A1
|
$370,707
|
|
RODRIGUEZ, GUSTAVO
|
NORTHSHORE UNIVERSITY HEALTHSYSTEM
|
|
Vitamin D and Photodynamic Therapy for Human Skin Cancer (SCC and BCC)
|
5R01CA204158-02
|
$463,965
|
|
MAYTIN, EDWARD
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Visualization and Epigenomic Characterization of Early Intestinal Tumorigenesis in Mice
|
5R01CA212374-02
|
$434,625
|
|
LAIRD, PETER
|
VAN ANDEL RESEARCH INSTITUTE
|
|
Vascular communication in metastatic brain colonization
|
5R01CA184594-05
|
$321,625
|
|
KLEMKE, RICHARD
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-06
|
$503,410
|
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-05
|
$644,932
|
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-05
|
$1,267,600
|
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using Single Cell Analysis to identify therapeutic vulnerabilities in leptomeningeal melanoma metastases
|
5R21CA216756-02
|
$224,460
|
|
SMALLEY, KEIRAN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Using genetically engineered mouse models of brain tumors to develop therapeutic nanoparticles & biomaterials
|
5R01CA195718-03
|
$633,241
|
|
HOLLAND, ERIC
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
uSHEAR Technology for Cancer Cell Purificaiton
|
5R21CA202849-03
|
$225,649
|
|
GARCIA, ANDRES
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
|
Unraveling the molecular control of a pro-metastatic regulatory network in melanoma
|
5R01CA184804-03
|
$387,731
|
|
TAVAZOIE, SOHAIL
|
ROCKEFELLER UNIVERSITY
|
|
University of Colorado NTCN Lead Academic Participating Site (LAPS)
|
5U10CA180834-05
|
$768,950
|
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding Uncertainties in Radiomics Studies
|
5R21CA216572-02
|
$139,200
|
|
COURT, LAURENCE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Understanding the role of ?B-Ras proteins in tumorigenesis
|
5R01CA206556-03
|
$384,782
|
|
GHOSH, SANKAR
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Understanding the origin,initiation,and progression of high-grade serous ovarian cancer
|
5R00CA179137-05
|
$236,746
|
|
KIM, JAEYEON
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Understanding Spatially Regulated Tumor-Inhibitory Function of Profilin-1 and its Deregulation in Breast Cancer
|
5R01CA181671-02
|
$348,844
|
|
SHAO, JIEYA
|
WASHINGTON UNIVERSITY
|
|
Understanding metabolic pathways that support redox homeostasis in cancer
|
5F32CA213810-02
|
$59,038
|
|
MUIR, ALEXANDER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Understanding How Ciliary Hedgehog Signaling Causes Medulloblastoma
|
5K08CA212279-02
|
$177,124
|
|
RALEIGH, DAVID
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Understanding and Improving Platinum Anticancer Drugs
|
5R01CA034992-36
|
$674,719
|
|
YILMAZ, OMER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Uncovering the role of individual RNA helicases in cancer through specific chemical inhibition
|
5F30CA203522-03
|
$49,524
|
|
BARKOVICH, KRISTER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
UM LAPs- U10 Grant
|
5U10CA180801-05
|
$763,048
|
|
ZALUPSKI, MARK
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
uCoil NMR platform for robust and high-throughput analysis of in vitro metabolic flux on living cells
|
5R21CA212958-02
|
$216,000
|
|
KESHARI, KAYVAN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-05
|
$623,007
|
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Tumor-stromal interactions as targets of tumor metastasis suppressors
|
5R01CA184494-04
|
$350,689
|
|
ROSNER, MARSHA
|
UNIVERSITY OF CHICAGO
|
|
Tumor suppressor p53 and its targets in checkpoint regulation
|
5R01CA210560-02
|
$366,502
|
|
LEE, SAM
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Tumor Molecular Profiling and Response to Immunotherapy in Advanced Biliary Cancers
|
5R03CA212877-02
|
$79,250
|
|
KELLEY, ROBIN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$474,811
|
$189,924
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Trimeric G proteins as Novel Targets in Cancer Progression
|
5F31CA206426-02
|
$36,375
|
|
KALOGRIOPOULOS, NICHOLAS
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Treatment of multiple myeloma using oncolytic myxoma virus
|
5R01CA194090-03
|
$341,981
|
|
BARTEE, ERIC
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Treatment of glioma with nanocombretastatin with MRI monitoring
|
5R01CA206190-03
|
$344,269
|
|
ALI, MESER
|
Henry Ford Health System
|
|
Translational Research in Breast Cancer (SPORE)
|
5P50CA186784-04
|
$2,300,000
|
$138,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translation addiction and targeting in colon cancer
|
1R01CA215481-01A1
|
$467,690
|
|
YU, JIAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Translating Novel Antitumor Targets of Vitamin E into New Chemopreventive Agents
|
5R01CA172576-05
|
$319,550
|
|
CLINTON, STEVEN
|
OHIO STATE UNIVERSITY
|
|
Translating genomic discoveries to improved outcomes for high risk acute leukemia
|
5R35CA197695-02
|
$1,077,000
|
|
MULLIGHAN, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Transcriptional Regulation of Immunosuppressive Macrophages by c-Maf in Cancer
|
5R01CA213990-02
|
$352,275
|
|
YAN, JUN
|
UNIVERSITY OF LOUISVILLE
|
|
Transcriptional CDKs as therapeutic targets in MYC-dependent cancers
|
5R01CA197336-03
|
$407,748
|
|
GEORGE, RANI
|
DANA-FARBER CANCER INST
|
|
Transcription repression in prostate cancer
|
5R01CA112226-09
|
$402,563
|
|
LOGAN, SUSAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Training of Academic Surgical Oncologists
|
2T32CA009599-30
|
$549,923
|
|
MERIC-BERNSTAM, FUNDA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Training in Interprofessional Education for Palliative Care in Oncology
|
5R25CA203637-02
|
$293,452
|
|
PFEIFER, MARK
|
UNIVERSITY OF LOUISVILLE
|
|
Towards the automation of MR spectroscopic imaging in patients with glioblashoma
|
5F30CA206291-03
|
$49,524
|
|
GURBANI, SAUMYA
|
EMORY UNIVERSITY
|
|
Topical Chemoprevention of Skin Cancer Biomarkers
|
5R01CA193885-03
|
$336,263
|
|
ELMETS, CRAIG
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
TlBr Detectors for High Resolution PET Imaging
|
5R01CA183994-04
|
$403,711
|
|
MITCHELL, GREGORY
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Tissue-specific tumor suppressor effects of p53
|
3R01CA200256-03S1
|
$78,178
|
$39,089
|
MANFREDI, JAMES
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
Total relevant funding to Gene Therapy for this search: $38,396,901
|